Bayer Cropscience Moat Analysis: Score & Risks
Bayer Cropscience Ltd.
A first-pass moat teardown of Bayer Cropscience Ltd., built from single-pass filing evidence. Free note — provisional, and the full two-pass deep dive may revise it.
First-pass narrow read — primary edge in Efficient Scale. Provisional, single-pass evidence.
Bayer Cropscience Ltd. scores 5.19 on MoatSCORE 6.0 — a narrow moat in Chemicals. This is a first-pass note: the dimensional read and the filing receipts below come from a single GFIP evidence pass, not the full two-pass deep corpus behind our flagship deep dives. Provisional — published free while the deep version is queued.
Seven dimensions of moat
Ordered by contribution. Each dimension carries a verified filing quote, graded [M] mechanism or [O] outcome.
“Interestingly enough, the Indian plants are much more flexible. They can move from one compound to the other. They can be switched over reasonably quickly, and they can make smaller batches.”
“Yeah, I mean, first of all, the advantage with corn seeds is I'm literally 100% backward integrated except maybe some licensing costs or so that will be there.”
“the agri entrepreneur sitting directly close to small farmer communities of 500 or 1000 farmers there is a very strong linkage established”
“464 study reports were utilized as part of the dossier submission to Central Insecticide Board and Registration Committee (CIB-RC) which will help BCSL to secure registration approvals in the years ahead.”
“Major reasons for that achievement were the increase in volumes and the favorable sales mix with the higher spring corn seeds. Moreover, price increases enabled us to partially offset inflationary pressure.”
“It is either the owner of, or entitled to use the intellectual property rights to these products”
D8 rating: ADEQUATE. Not part of the moat score — it governs the cost of equity and the fade window. First-pass; not yet deep-reviewed.
The barrier gate — first-pass
Effective barrier 5 — below 6, so the band is capped narrow. First-pass estimate.
Deep two-pass review. This draft rests on a single GFIP evidence pass; the full 10-year AR + concall corpus may move the read.
The barrier gate. A firmer replication or bypass estimate is the most likely thing to shift the band.
Adverse events. Any governance, regulatory or funding shock captured in D8 could re-rate the fade window.
Where this note fits. This company is one of 509 Indian companies we have scored for moat durability — 370 narrow, 126 narrow-trending-wide, none wide. Every score, dimension by dimension, is free in the Moat Screener.
Member discussion